Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

clinical trial

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT04011410

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2021-05-01
P921main subjectmetastatic prostate carcinomaQ55779807
Oligometastatic prostate cancer and salvage lymph node dissection: systematic reviewQ57112655
P2899minimum age18
P1132number of participants20
P580start time2019-07-01
P8363study typeinterventional studyQ78089383
P1476titlePhase 2 Study of Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Search more.